AP9801280A0 - Solubilized sertraline compositions - Google Patents

Solubilized sertraline compositions

Info

Publication number
AP9801280A0
AP9801280A0 AP9801280A AP9801280A AP9801280A0 AP 9801280 A0 AP9801280 A0 AP 9801280A0 AP 9801280 A AP9801280 A AP 9801280A AP 9801280 A AP9801280 A AP 9801280A AP 9801280 A0 AP9801280 A0 AP 9801280A0
Authority
AP
ARIPO
Prior art keywords
compositions
solubilized
solubilized sertraline
sertraline compositions
sertraline
Prior art date
Application number
AP9801280A
Other versions
AP1192A (en
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP9801280(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP9801280A0 publication Critical patent/AP9801280A0/en
Application granted granted Critical
Publication of AP1192A publication Critical patent/AP1192A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1998/001280A 1997-07-01 1998-06-25 Solubilized sertraline compositions. AP1192A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (2)

Publication Number Publication Date
AP9801280A0 true AP9801280A0 (en) 1998-06-30
AP1192A AP1192A (en) 2003-07-23

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001280A AP1192A (en) 1997-07-01 1998-06-25 Solubilized sertraline compositions.

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1402629A (en) 1999-12-23 2003-03-12 辉瑞产品公司 Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (en) 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
MY162940A (en) 2009-08-19 2017-07-31 Eisai R&D Man Co Ltd Quinoline derivative-containing pharmaceutical composition
WO2011081118A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Pharmaceutical composition for oral administration
JPWO2011081117A1 (en) * 2009-12-29 2013-05-09 興和株式会社 Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process
CN114894736B (en) * 2022-05-20 2025-03-21 中化地质矿山总局地质研究院 A method for determining nitrate in chloride-type brine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (en) * 1989-08-30 1993-11-15 Pfizer USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
SK181099A3 (en) 2000-07-11
HN1998000102A (en) 1999-01-08
EP0999829A1 (en) 2000-05-17
IL133076A0 (en) 2001-03-19
IS5260A (en) 1999-11-19
CO4940495A1 (en) 2000-07-24
HUP0002236A3 (en) 2003-12-29
EA002481B1 (en) 2002-06-27
AU742535B2 (en) 2002-01-03
OA11243A (en) 2003-07-24
HUP0002236A2 (en) 2003-08-28
PA8454301A1 (en) 2000-09-29
KR20010013365A (en) 2001-02-26
CN1261794A (en) 2000-08-02
EA199900962A1 (en) 2000-08-28
PL337804A1 (en) 2000-09-11
BG103918A (en) 2000-07-31
TW550087B (en) 2003-09-01
HRP980377A2 (en) 1999-04-30
CA2290974A1 (en) 1999-01-14
AR015917A1 (en) 2001-05-30
BR9810739A (en) 2000-09-12
ZA985708B (en) 2000-01-10
TR199903297T2 (en) 2000-07-21
UY25071A1 (en) 2000-12-29
WO1999001120A1 (en) 1999-01-14
DZ2548A1 (en) 2003-02-08
PE97199A1 (en) 1999-10-05
CA2290974C (en) 2004-04-27
IL133076A (en) 2003-12-10
JP2000514100A (en) 2000-10-24
YU68299A (en) 2002-06-19
NO996520L (en) 2000-02-29
NO996520D0 (en) 1999-12-28
KR100366373B1 (en) 2003-01-14
UA67741C2 (en) 2004-07-15
AU7544898A (en) 1999-01-25
AR040279A2 (en) 2005-03-23
MA24587A1 (en) 1998-12-31
AP1192A (en) 2003-07-23
TNSN98124A1 (en) 2005-03-15
ID23429A (en) 2000-04-20
AR040280A2 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
HUP9903759A3 (en) Abtimicrobial compositions
GB9726969D0 (en) Mousse-forming shampoo compositions
GB9726814D0 (en) Compositions
GB9702238D0 (en) Compositions
GB9704524D0 (en) Composition
IL130856A0 (en) Peroxetine compositions
GB9726970D0 (en) Shampoo compositions
AP9801280A0 (en) Solubilized sertraline compositions
GB9726543D0 (en) Novel compositions
GB2331703B (en) Disinfectant compositions
GB9724838D0 (en) Compositions
GB9701031D0 (en) Composition
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
GB9705813D0 (en) Novel compositions
GB9712981D0 (en) Compositions
GB9705110D0 (en) Composition
GB2336368B (en) Compositions
GB9709126D0 (en) Compositions
GB9709128D0 (en) Compositions
GB9722734D0 (en) Compositions
GB9719640D0 (en) Compositions
GB9704427D0 (en) Compositions
GB9717523D0 (en) Compositions
GB9714273D0 (en) Compositions